Freeman J. Clinical decision making in diabetes: Use of glucagon-like peptide-1 (GLP-1) receptor agonists in clinical practice (where, when, and which?)–Introduction. OFP [Internet]. 2013 Jan. 1 [cited 2024 Jul. 3];5(1):31-2. Available from: https://ofpjournal.com/index.php/ofp/article/view/299